The company was founded in 1997 by Dr Graham March, a pharmacist with substantial experience of the formulation of medicines gained whilst working at major pharmaceutical companies and within the UK’s National Health Service.
Dr March spent several years formulating medicines at Great Ormond Street Hospital, the world-renowned children’s hospital in London. Whilst working at the hospital, Dr March identified the need for a private sector company dedicated to developing medicines for children with rare diseases and for other patient groups.
Dr March, along with a small team of formulation experts at Veriton Pharma, has since developed more than 60 “specials” for a targeted range of therapeutic areas.
In general, liquids have been produced for children and tablets for older children and adults. Injections have also been manufactured to treat patients requiring emergency treatment. The company has grown rapidly, supplying products to more than 25 countries.
Unlicensed 'Special' Products
Our heritage of developing tailor-made medications enables Veriton Pharma to provide a range of unlicensed therapy options for those patients whose clinical needs are not met by licensed medications.
News
- Young Epilepsy and Veriton Pharma Ltd announce key partnership agreement in support of the charity’s ‘Rules 4 Schools’ campaign
Young Epilepsy and Veriton Pharma Ltd (Veriton) have announced a key agreement, where the organisations will work in partnership to deliver the ‘Rules 4 Schools” element of the charity’s newly… Read More
- Epistatus® 10 Mg (In 1 Ml) Oromucosal Solution Midazolam Available on Nhs Prescription Is Approved For Use By Both the Scottish Medicines Consortium (Smc) and the All Wales Medicines Strategy Group (Awmsg)
Epistatus is licensed for use in the treatment of prolonged, acute convulsive seizures in children and adolescents aged 10 to less than 18 years, who have been diagnosed with epilepsy1. Epistatus… Read More
- New company name for Special Products Ltd
2nd October 2017: Weybridge, UK: Today, Veriton Pharma Ltd is announced as the new company name for Special Products Ltd. This name change has occurred both to incorporate the company’s… Read More
- Epistatus® 10 mg oromucosal solution midazolam – now available to prescribe
8th September 2017: Special Products Ltd is pleased to announce that Epistatus® 10 mg Oromucosal Solution, Midazolam, is now available to prescribe. The NHS price for a single 10mg in… Read More